Market Tracker

09/28 5:48pm ET

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

35.55
Delayed Data
As of 3:59pm ET
 +0.09 / +0.25%
Today’s Change
31.08
Today|||52-Week Range
80.25
-53.70%
Year-to-Date
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Novartis (NVS) Presents Positive Data on Cardiovascular Drug
Sep 19 / Zacks.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
Sep 16 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content
Roche Ocrevus Positive in Phase III Multiple Sclerosis Trials
Sep 15 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Gets Favorable CHMP Opinion for Olaratumab
Sep 19 / Zacks.com - Paid Partner Content
Shire's Immunodeficiency Treatment Cuvitru Gets FDA Approval
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.46
Today’s open36.02
Day’s range34.83 - 36.03
Volume677,393
Average volume (3 months)816,212
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-58.84%
Earnings growth (next 5 years)+80.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales12.74
Price/Book5.98

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.05+0.74%
SUPNSupernus Pharmaceuti...+0.10+0.38%
PTLAPortola Pharmaceutic...+0.02+0.09%
CEMPCempra Inc+0.19+0.73%
Data as of 4:00pm ET, 09/28/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.04
Annual revenue (last year)$249.0M
Annual profit (last year)$1.9M
Net profit margin0.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts